![Michael Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Huang
Direktor/Vorstandsmitglied bei
ELIXIRON IMMUNOTHERAPEUTICS (CAYMAN) LIMITED
Profil
Michael L.
Huang was the founder of Neurovive Pharmaceutical Asia, Inc., founded in 2014, where the title held was Chief Executive Officer from 2014 to 2017.
Current jobs include Director at Windgap Medical, Inc. since 2021, Director at Viracta Subsidiary, Inc. since 2019, Director at Regenacy Pharmaceuticals LLC, Director at Point Robotics Medtech, Inc., and Director at Elixiron Immunotherapeutics (Cayman) Ltd. since 2019.
Former jobs include Director at Sunesis Pharmaceuticals, Inc., Director at Fractyl Health, Inc., Independent Director at Frequency Therapeutics, Inc., Independent Director at Viracta Therapeutics, Inc. from 2019 to 2022, Director at Digestive Health Specialists PC, and Head-Investor Relations at TWi Pharmaceuticals, Inc. Education includes undergraduate studies at The University of Texas at Austin, graduate studies at The University of Texas at Arlington, and an MBA from Jones Graduate School of Business.
Aktive Positionen von Michael Huang
| Unternehmen | Position | Beginn |
|---|---|---|
| ELIXIRON IMMUNOTHERAPEUTICS (CAYMAN) LIMITED | Direktor/Vorstandsmitglied | 25.07.2019 |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Direktor/Vorstandsmitglied | 01.01.2019 |
Regenacy Pharmaceuticals LLC
 Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops novel treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors | Direktor/Vorstandsmitglied | - |
Point Robotics Medtech, Inc.
 Point Robotics Medtech, Inc. Wholesale DistributorsDistribution Services Manufactures machinery and equipment products | Direktor/Vorstandsmitglied | - |
Windgap Medical, Inc.
 Windgap Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | 01.01.2021 |
Ehemalige bekannte Positionen von Michael Huang
| Unternehmen | Position | Ende |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 23.08.2022 |
Digestive Health Specialists PC | Direktor/Vorstandsmitglied | 01.02.2022 |
Neurovive Pharmaceutical Asia, Inc. | Vorstandsvorsitzender | 01.01.2017 |
| TWI PHARMACEUTICALS INC | Investor Relations Kontakt | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Michael Huang
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
50
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Windgap Medical, Inc.
Windgap Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Arlington
 The University of Texas at Arlington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fractyl Health, Inc.
 Fractyl Health, Inc. BiotechnologyHealth Technology Develops and sells therapeutics for metabolic diseases, type 2 diabetes & obesity | Health Technology |
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Health Technology |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
Regenacy Pharmaceuticals LLC
Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops novel treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors | Health Technology |
Point Robotics Medtech, Inc.
Point Robotics Medtech, Inc. Wholesale DistributorsDistribution Services Manufactures machinery and equipment products | Distribution Services |
Neurovive Pharmaceutical Asia, Inc. | |
Jones Graduate School of Business
 Jones Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
Elixiron Immunotherapeutics, Inc.
 Elixiron Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision immunotherapy drugs | Health Technology |
Digestive Health Specialists PC |
